-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704A.O2.6 704. Cellular Immunotherapies: Cellular Therapies for Low and High Grade Lymphomas

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Clinical Trials, Biological, Lymphomas, Clinical Research, B Cell Lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Clinically Relevant, Diseases, Therapies, Immunotherapy, Lymphoid Malignancies
Monday, December 13, 2021: 2:45 PM-4:15 PM
A411-A412, Level 4, Building A (Georgia World Congress Center)
Moderators:
Aleksandr Lazaryan, MD, Moffitt Cancer Center, Moffitt Cancer Center and LaQuisa C. Hill, MD, Baylor College of Medicine, Houston Methodist Hospital
Disclosures:
Hill: Incyte: Membership on an entity's Board of Directors or advisory committees.
2:45 PM

Sattva S. Neelapu, MD1, Michael Dickinson, MBBS2, Javier Munoz, MD, MS, MBA, FACP3, Matthew L. Ulrickson, MD3, Catherine Thieblemont, MD, PhD4, Olalekan O. Oluwole, MBBS, MPH5, Alex F. Herrera, MD6, Chaitra S. Ujjani, MD7, Yi Lin8, Peter A. Riedell, MD9, Natasha Kekre, MD, FRCPC10, Sven de Vos11, Christine Lui, MS12*, Francesca Milletti, PhD12*, Jinghui Dong, PhD12*, Hairong Xu, MD, PhD12* and Julio C. Chavez, MD13

1Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
2Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and and the University of Melbourne, Melbourne, VIC, Australia
3Banner MD Anderson Cancer Center, Gilbert, AZ
4Department of Hemato-Oncology, Saint Louis Hospital, Paris, France
5Vanderbilt-Ingram Cancer Center, Nashville, TN
6City of Hope National Medical Center, Duarte, CA
7Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA
8Mayo Clinic, Rochester, MN
9Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
10The Ottawa Hospital, Ottawa, ON, Canada
11David Geffen School of Medicine at UCLA, Santa Monica, CA
12Kite, a Gilead Company, Santa Monica, CA
13Moffitt Cancer Center, Tampa, FL

3:00 PM

Ian W. Flinn, MD, PhD1, Ulrich Jaeger2, Nirav N. Shah, MD3, Didier Blaise4, Javier Briones, MD, PhD5*, Leyla Shune, MD6, Nicolas Boissel, MD, PhD7, Attilio Bondanza, MD8*, Darlene Lu, PhD9*, Xu Zhu, PhD9*, Boris Engels, PhD9*, Jennifer L Brogdon, PhD9*, Jennifer Mataraza, PhD9*, Jaclyn Davis, MD10, Anne Laure Marchal8*, Luisa Mariconti, MSc8*, Michele Moschetta, MD, PhD8*, Laure Moutouh-de Parseval, MD8*, Pere Barba, MD, PhD11* and Michael Dickinson, MBBS12

1Sarah Cannon Research Institute-Tennessee Oncology, Nashville, TN
2Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Vienna General Hospital – Medical University of Vienna, Vienna, Austria
3Medical College of Wisconsin, Milwaukee, WI
4Département d'hématologie, Programme de transplantation et de thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Aix-Marseille University, Institut Paoli Calmettes, Marseille, France
5Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain
6University of Kansas Medical Center, Kansas City, KS
7St-Louis Hospital, APHP, Adolescents and Young Adults Hematology Department, Paris, France
8Novartis Institutes for BioMedical Research, Basel, Switzerland
9Novartis Institutes for BioMedical Research, Cambridge, MA
10Novartis Institutes for BioMedical Research, East Hanover, NJ
11Hematology Department, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain
12Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

3:15 PM

Matthew J. Frank, MD, PhD1,2*, John H. Baird, MD1,2, Shabnum Patel, PhD3*, Juliana Craig, BA1,2*, Jay Y. Spiegel, MD, FRCPC1,2, Zachary Ehlinger, MS3*, Harshini Chinnasamy, MS2*, Sheren F. Younes, MD, PhD4*, Jean S. Oak, MD, PhD5*, Yasodha Natkunam, MD, PhD4, Warren D. Reynolds, BS3*, Maria Iglesias, BS1,2*, Emma Crawford, BS2,6*, Hrishikesh K. Srinagesh, MD1, Emily L. Egeler, PhD2*, Sally Arai, MD, MS1, Laura J. Johnston, MD1, Robert Lowsky, MD1, Robert S. Negrin, MD1, Andrew R. Rezvani, MD1, Parveen Shiraz, MD7, Surbhi Sidana, MD1,2, Wen-Kai Weng, MD, PhD1, Liora M. Schultz, MD8, Sneha Ramakrishna, MD8, Kara L. Davis, DO9, Bita Sahaf, PhD2*, Steven A. Feldman, PhD2*, Crystal L. Mackall, MD10,11, David B. Miklos, MD, PhD1,2 and Lori Muffly, MD2,12

1Division of BMT and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
2Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA
3Center for Cancer Cell Therapy, Stanford University, Stanford, CA
4Department of Pathology, Stanford University School of Medicine, Stanford, CA
5Department of Pathology, Stanford University Medical Center, Stanford, CA
6Division of BMT and Cellular Therapy, Stanford University Hospital, Stanford, CA
7Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
8Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA
9Department of Pediatrics, Division of Hematology, Oncology and Stem Cell Transplant, Stanford University School of Medicine, Stanford, CA
10Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
11Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
12Division of BMT and Cellular Therapy, Associate Professor of Medicine Bone & Marrow Transplantation Stanford University Medical Center, Stanford, CA

3:30 PM

Natalie S Grover, MD1, Anastasia Ivanova, PhD1*, Dominic T. Moore, MPH, MS1*, Catherine Joyce Arago Cheng, BS1*, Caroline Babinec, BA1*, John West, PhD1*, Tammy Cavallo, BS1*, J. Kaitlin Morrison, PhD1*, Faith Brianne Buchanan, PA1*, Edith Bowers, MD, PhD2*, Christopher Dittus, DO1, Anne W. Beaven, MD1, Gianpietro Dotti, MD1*, Jonathan S. Serody, MD1 and Barbara Savoldo, MD, PhD1*

1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
2Department of Dermatology, University of North Carolina, Chapel Hill, NC

3:45 PM

Charles Herbaux, MD1, Caroline Bret, PhD, PharmD2*, Roberta Di Blasi, MD, PhD3*, Emmanuel Bachy, MD, PhD4*, David Beauvais, MD5*, Elodie Gat6*, Thomas Gastinne, MD7*, Florence Broussais8*, Guillaume Cartron, MD, PhD9*, Alexis Cuffel10*, Loic Ysebaert, MD, PhD11*, Mikael Roussel, MD, PhD12*, Krimo Bouabdallah13*, Julien Guy, MD14*, Arnaud Campidelli15*, François Van Laethem16*, Rene-Olivier Casasnovas, MD17*, Remy Dulery18*, Franck Morschhauser, MD, PhD19*, Sophie Caillat-Zucman, MD, PhD20*, Roch Houot21* and Steven Le Gouill22

1Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
2University of Montpellier, UFR Medecine, Montpellier, France
3Department of Hematology, Assistance Publique Hôpitaux de Paris - Hopital Saint-Louis, University of Paris, Paris, France
4Department of Hematology, Lyon Sud Hospital, Lyon, France
5Hématologie clinique, CHU de Lille, Lille, France
6Institut Carnot CALYM, PIERRE-BENITE, FRA
7Clinical Hematology, University Hospital of Nantes,, Nantes Cedex 1, France
8LYSARC, Lyon, France
9Département d'Hématologie clinique, CHU de Montpellier, Montpellier, France
10APHP, hôpital Saint-Louis; Immunologie, Paris, France
11Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
12CHU Rennes, Rennes, France
13Department of Hematology and Cell Therapy, University Hospital, Bordeaux, France
14Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Dijon, DIJON, France
15CHU, Nancy, France
16CHU, Montpellier, France
17Department of Hematology, CHU Dijon, Dijon, France
18Saint-Antoine Research Center, Inserm UMR938, Sorbonne Université, Paris, France
19Hematology Department, Lille University Hospital, Lille, France
20Laboratory of Immunology, Saint Louis Hospital, APHP, Paris, France
21CHU, Rennes, FRA
22Service d’hématologie clinique du CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France

4:00 PM

Yucai Wang, MD, PhD1, Preetesh Jain, MBBS, MD, DM, PhD2, Frederick L. Locke, MD3, Javier Munoz, MD, MS, MBA, FACP4, Matthew J. Maurer, MS, DMSc5, Amer Beitinjaneh, MD, MPH, MSc6*, Matthew J. Frank, MD, PhD7, Saurabh Dahiya, MD8, Joseph P. McGuirk, DO9, Miriam T. Jacobs, MD10, Andre H. Goy, MD11*, Julie M. Vose, MD, MBA12, Brian T. Hill, MD13, Olalekan O. Oluwole, MBBS, MPH14, Abhinav Deol15, Bijal D. Shah, MD16, Jonas Paludo, MD1, Trent Wang, DO, MPH6, Lazaros J. Lekakis, MD6*, David B. Miklos, MD, PhD7, Aaron P. Rapoport, MD8, Armin Ghobadi, MD10, Sattva S. Neelapu, MD2, Yi Lin1, Michael Wang, MD2 and Michael D. Jain, MD, PhD3

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
4Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
5Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
6Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
7Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University Hospital, Stanford, CA
8University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
9Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwoon, KS
10Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
11Division of Lymphoma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
12Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE
13Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
14Vanderbilt University Medical Center, Nashville, TN
15Karmanos Cancer Institute, Wayne State University, Detroit, MI
16Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL

*signifies non-member of ASH